Participant‐rated global improvement · people with chronic plaque psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in percentage of participants reaching PASI 75 compared with oral PUVA (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with chronic plaque psoriasis
NB‐UVB showed no clear difference in withdrawal due to side‐effects compared with oral PUVA (low certainty).
1 finding from 1 review
Clearance rate · people with chronic plaque psoriasis
1 finding from 1 review
All studies · patients with the initiation of oral anticoagulation
It is very uncertain whether 5 mg changes all studies compared with 10 mg (very low certainty).
1 finding from 1 review
Single INR measure · patients with the initiation of oral anticoagulation
It is very uncertain whether 5 mg changes single INR measure compared with 10 mg (very low certainty).
1 finding from 1 review
Consecutive INR measures · patients with the initiation of oral anticoagulation
It is very uncertain whether 5 mg changes consecutive INR measures compared with 10 mg (very low certainty).
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · children with cystic fibrosis
1 finding from 1 review
Time to next pulmonary exacerbation · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: number of treatment‐related adverse events · children with cystic fibrosis
1 finding from 1 review
Hospital admissions · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
New acquisition of CF pathogens: PA (mean change in PA count (log10 PA CFU/g sputum)) · children with cystic fibrosis
1 finding from 1 review
Need for additional antibiotic therapy · children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · children with cystic fibrosis
1 finding from 1 review
Change in burn‐related pruritus (VAS) ( · people with postburn pruritus
Doxepin cream showed no clear difference in change in burn‐related pruritus (VAS) ( compared with oral antihistamine (low certainty).
1 finding from 1 review
Somnolence · people with postburn pruritus
It is very uncertain whether doxepin cream changes adverse events (somnolence) compared with oral antihistamine (very low certainty).
1 finding from 1 review
Pain · people with postburn pruritus
The review found no eligible studies for this question.
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Vaginal delivery not achieved within 24 hours · third trimester induction of labour in women with a viable fetus
Balloon (Foley or ATAD) probably leads to higher vaginal delivery not achieved within 24 hours compared with low‐dose oral misoprostol (moderate certainty).
1 finding from 1 review